Usefulness of determining the blood levels of B-type natriuretic peptide in the evaluation of cardiotoxicity in children treated with anthracyclines;Przydatność oznaczania stezenia peptydu natriuretycznego typu B w surowicy krwi w ocenie kardiotoksyczności poantracyclinowej u dzieci.

Medycyna wieku rozwojowego

Volumn 10, Issue 3 Pt 1, 2006, Pages 767-774

  Jackowska, Teresa ^a   Wasilewski, Robert ^a  

^a Medical University of Warsaw Katedra i Klinika Pediatrii Hematologii i Onkologii   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; ANTINEOPLASTIC ANTIBIOTIC; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; PEPTIDE FRAGMENT; PRO BRAIN NATRIURETIC PEPTIDE (1 76); PRO-BRAIN NATRIURETIC PEPTIDE (1-76); UNCLASSIFIED DRUG;

BLOOD; CARDIOMYOPATHY; CHEMICALLY INDUCED DISORDER; CHILD; CONGESTIVE HEART FAILURE; DOPPLER ECHOCARDIOGRAPHY; DRUG EFFECT; ELECTROCARDIOGRAPHY; FORWARD HEART FAILURE; HEART; HUMAN; LEUKEMIA; LYMPHOMA; NEOPLASM; REVIEW;

ANTHRACYCLINES; ANTIBIOTICS, ANTINEOPLASTIC; BIOLOGICAL MARKERS; CARDIAC OUTPUT, LOW; CARDIOMYOPATHIES; CHILD; ECHOCARDIOGRAPHY, DOPPLER; ELECTROCARDIOGRAPHY; HEART; HEART FAILURE, CONGESTIVE; HUMANS; LEUKEMIA; LYMPHOMA; NATRIURETIC PEPTIDE, BRAIN; NEOPLASMS; PEPTIDE FRAGMENTS;

EID: 34247868065     PISSN: 1428345X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (24)